FlowCardia

company

About

FlowCardia designs and develops catheter-based technologies for the treatment of totally occluded coronary and peripheral arteries.

  • 1 - 10

Details

Last Funding Type
Series C
Last Funding Money Raised
$30M
Industries
Biotechnology,Health Care,Medical Device,Therapeutics
Founded date
Jan 1, 2002
Number Of Employee
1 - 10
Operating Status
Active

FlowCardia, Inc. is a medical device company founded in 2002 to design and develop a portfolio of innovative, catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. Chronic Total Occlusions (CTOs) are considered one of the last major clinical challenges in interventional therapy. The historic absence of safe and effective CTO recanalization devices is a major reason a large number of patients are still referred to coronary and peripheral bypass surgery and lower limb amputation.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$30M
FlowCardia has raised a total of $30M in funding over 2 rounds. Their latest funding was raised on Aug 30, 2007 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 30, 2007 Series C $30M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
FlowCardia is funded by 1 investors. Rockport Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Rockport Venture Partners Series C